FDA Approves Alvotech’s New Simlandi Manufacturing Process
Alvotech said the FDA approved a new manufacturing process for Simlandi, its biosimilar to Humira. Shares rose 8% to $5.41 in morning trading.
By Chris WackAlvotech shares rose after the company said the Food and Drug Administration approved a new manufacturing process for Simlandi, its biosimilar to Humira.The stock was 8% higher, at $5.41, in morning trade, and is 37% lower in the past 12 months.The biotechnology company said the FDA ap…